Cholesterol API Market - Top Companies and Manufacturers

Companies Dominating the Cholesterol API Market

Thermo Fisher Scientific Holdings, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Croda International Plc
Bristol Myers Squibb Company (BMS)
Evonik Industries AG
Dishman Carbogen Amcis Ltd
Hänseler AG
Caesar & Loretz GmbH
Akums Drugs & Pharmaceuticals Ltd.
Tokyo Chemical Industry Co., Ltd.
Cayman Chemical Company

Browse Key Market Insights with Data Illustration:

Cholesterol API Market Size & Share, Growth Trends 2036

In the News

Croda International Plc, announced the support of the UK government to the expansion of its manufacturing facility which is estimated to boost the development of high-purity lipid systems for next-generation nucleic acid drugs such as mRNA vaccines.
Bristol Myers Squibb Company (BMS), announced the successful acquisition of Turning Point Therapeutics, Inc. ("Turning Point"). As a result of the acquistion, Bristol Myers Squibb gains access to an investigational medicines pipeline focused on repotrectinib, the most common mutation associated with oncogenesis.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cholesterol API is evaluated at USD 291.65 million.

Cholesterol API Market size was over USD 281.3 million in 2023 and is expected to exceed USD 504.76 million by 2036, witnessing over 4.6% CAGR during the forecast period i.e., between 2024-2036. Growing use of liposomal formulations in drug delivery systems, surge in anticancer therapies, and escalating clinical trials of mRNA vaccines will propel the market growth.

North America is projected to hold 39% industry share by 2036, backed by growing cases of various types of cancers, rising healthcare expenditure, increasing expenditure in research and development of medical and health paradigm, and the existence of several well-known drug manufacturers in the region.

The major players in the market are Thermo Fisher Scientific Holdings, Inc., Croda International Plc, Bristol Myers Squibb Company (BMS), Evonik Industries AG, Dishman Carbogen Amcis Ltd, HÃƒÂ¤nseler AG, Caesar & Loretz GmbH, and others.

Cholesterol API Market - Top Companies and Manufacturers

Companies Dominating the Cholesterol API Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the cholesterol API market worth?

Why is the demand for cholesterol API growing?

Which region dominated the majority of cholesterol API industry share?

Who are the top cholesterol API companies?